# Abdera Therapeutics

> Abdera Therapeutics is a precision oncology biotech engineering antibody-based radiopharmaceuticals that deliver therapeutic radioisotopes directly to tumor cells while sparing healthy tissue. Built around its proprietary ROVEr platform, the company is advancing ABD-147 in Phase 1 trials for small cell lung cancer and large cell neuroendocrine carcinoma, with a second program, ABD-320, on deck.

- **Founded:** 2021
- **Headquarters:** South San Francisco, California, United States
- **Founders:** Adam Judge (Co-Founder), Lana Janes (Co-Founder, SVP Operations & Innovation), Mike Abrams (Co-Founder)
- **Team size:** ~67
- **Products:** ROVEr Platform, ABD-147, ABD-320
- **Notable:** Raised $142M across Series A and B in 2023, Named to FierceBiotech's Fierce 15 list, Lori Lyons-Williams named a 2025 CNBC Changemaker

## Products & services

- **ROVEr Platform** — Radio Optimized Vector Engineering - a proprietary drug discovery platform that designs antibody-based radiopharmaceuticals with tunable pharmacokinetics, optimized antigen-binding domains, and chelated radioisotopes for both alpha and beta therapy.
- **ABD-147** — Lead radiopharmaceutical program targeting DLL3-expressing tumors, currently in Phase 1 clinical trials for small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC).
- **ABD-320** — Second pipeline program addressing multiple solid tumor indications; clinical development anticipated to begin in 2026.

## Achievements

- Raised $142M across Series A and B in 2023
- Named to FierceBiotech's Fierce 15 list
- Lori Lyons-Williams named a 2025 CNBC Changemaker
- Advanced ABD-147 into Phase 1 clinical trials

## Latest updates

- **2025-02** — CEO Lori Lyons-Williams named 2025 CNBC Changemaker.
- **2024-08** — Named a FierceBiotech Fierce 15 nominee.
- **2023-04** — Emerged from stealth with $142M in combined Series A and B financing.

## Links

- Website: https://abderatx.com
- LinkedIn: https://www.linkedin.com/company/abdera-therapeutics
- Twitter/X: https://twitter.com/abdera_thera

---

Profile page: https://yespress.io/abdera-therapeutics
Published by YesPress — https://yespress.io
Last updated: 2026-05-19